Community Forum top_calendar.gif top_members.gif top_faq.gif top_search.gif top_home.gif    

Go Back   Community Forum > The Internet Medical Journal > Editorials
User Name
Password
FAQ Members List Calendar Search Today's Posts Mark Forums Read


 
 
Thread Tools Search this Thread Display Modes
Prev Previous Post   Next Post Next
  #1  
Old September 24th, 2001, 13:35
sysadmin sysadmin is offline
Administrator
 
Join Date: 2001
Posts: 1,085
1999.07.05 New Treatments for Post-Menopausal Hormone Replacement Therapy

It is too early to tell, but promising research may yet come up with improved hormone replacement therapy for post-menopausal women. There's only one medical pearl in this issue, but you can count on more to come regarding the use of raloxifene (Evista) as an alternative to estrogen. Raloxifene is a selective estrogen receptor modulator (SERM) that has the good benefits of estrogen but fewer adverse effects. Namely, this class of pharmaceuticals helps decrease osteoporosis and cardiovascular disease without increasing the risk of breast cancer. Apparently, raloxifene was originally designed to prevent and treat breast cancer, but it didn't work as well as tamoxifen. Now, the medicine is often used as a second line hormone replacement therapy because of its favorable effects on bone density and heart disease. At this point in time, however, estrogen remains my first choice because of the extensive research demonstrating proven, and clinically significant, positive effects upon the prevention of osteoporosis, heart disease, and dementia. Unfortunately, the significance of the effects of raloxifene is still largely unproven.
Reply With Quote
 


Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is Off
HTML code is On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Withdrawal of Thyroid Replacement Therapy Not Necessary With Tc-99m MIBI sysadmin News 0 July 4th, 2004 12:25
Estrogen Replacement Therapy and Ovarian Cancer sysadmin News 0 February 20th, 2004 17:18
July 2002 sysadmin News 0 August 12th, 2002 19:08


All times are GMT -8. The time now is 21:14.


Powered by: vBulletin Version 3.0.3
Copyright ©2000 - 2018, Jelsoft Enterprises Ltd.



Be careful about reading health books. You may die of a misprint.  
- Mark Twain (1835 - 1910)

We are committed to your good health. That means that while we provide editorial medical information, we must insist that you work with your own doctor in regards to your personal health issues. All content on Medjournal.Com is strictly editorial. It constitutes medical opinion, NOT ADVICE. We do not endorse or recommend the content of Medjournal.com or the sites that are linked FROM or TO Medjournal.com. Use common sense by consulting with your doctor before making any lifestyle changes or other medical decisions based on the content of these web pages. Medjournal.Com and the Internet Medical Journal shall not be held liable for any errors in content, advertising, or for any actions taken in reliance thereon.